NEW YORK, Aug. 27 – Shares in German firm MWG Biotech slid 28 percent on Friday after its chief executive announced his resignation in light of an impending core operating loss for the year.

CEO Michael Weichselgartner, who founded the biotechnology equipment manufacturer, will be replaced on Sept. 1 by Matthias Schönermark, a consultant for MWG from the Boston Consulting Group, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.